Insider plans sale of 3,620 restricted shares (NYSE: DRI)

Rhea-AI Filing Summary

Insider sale filing for restricted shares. A Form 144 notice indicates 3,620 shares of Common stock tied to restricted stock vesting under a registered plan are listed for sale. The filing shows an aggregate value of $731,837.30 and is dated 04/17/2026. The restricted shares vested on 07/28/2025 and are linked to services rendered.

Key Figures

Shares listed for sale: 3,620 shares Aggregate value: $731,837.30 Form date: 04/17/2026

3 metrics

Shares listed for sale 3,620 shares Restricted stock vesting under a registered plan (07/28/2025)

Aggregate value $731,837.30 Value reported on Form 144 (04/17/2026)

Form date 04/17/2026 Date of the Form 144 filing

Key Terms

Restricted stock, Form 144, Registered plan, Services Rendered

4 terms

Restricted stock financial

"Restricted stock vesting under a registered plan"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Registered plan financial

"Restricted stock vesting under a registered plan"

Services Rendered other

"07/28/2025 | Restricted stock vesting under a registered plan | Services Rendered"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3620	731837.30	114535003	04/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/28/2025	Restricted stock vesting under a registered plan	Issuer			3620	07/28/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does DRI's Form 144 disclose about the shares?

The filing discloses a proposed sale of 3,620 shares of Common stock tied to restricted stock vesting under a registered plan. It lists an aggregate value of $731,837.30 and shows the vesting date as 07/28/2025.

When were the restricted shares for DRI vested?

The restricted shares are shown as vested on 07/28/2025. The Form 144 notice itself is dated 04/17/2026, indicating the filer is providing the required sale notice after vesting occurred.

Who is listed as the broker or selling party on the Form 144?

The filing references Morgan Stanley Smith Barney LLC at 1 New York Plaza as the broker/agent. The sales are tied to restricted stock issued for services rendered under a registered plan.

Does the Form 144 show proceeds going to the issuer (DRI)?

The Form 144 lists the securities as restricted stock sold by an insider; proceeds treatment is not described as company proceeds. The entry labels the securities as issued for services rendered, not as an issuer cash raise.